ALDEYRA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
ALDEYRA THERAPEUTICS, INC. (ALDX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 670.82 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-06
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 278.66K shares.
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 392.16K shares.
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 8.94K shares, a 97.15% decline year-over-year.
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 0.00 shares.
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 124.72K shares, a 63.85% decline from fiscal 2024.
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 344.99K shares, a 14.70% increase from fiscal 2023.
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 300.77K shares, a 59.26% decline from fiscal 2022.
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 738.22K shares, a 133.32% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 278.66K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 670.82K shares 10-Q · filed 2026-08-06 | 679.76K shares derived: sum of 3 quarters · filed 2026-08-06 | 679.76K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 392.16K shares 10-Q · filed 2026-05-07 | 401.10K shares derived: sum of 2 quarters · filed 2026-05-07 | 401.10K shares derived: sum of 3 quarters · filed 2026-05-07 | |
| 2025-12-31 | 8.94K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 8.94K shares derived: sum of 2 quarters · filed 2026-02-27 | 124.72K shares 10-K · filed 2026-02-27 | |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 115.78K shares 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | 115.78K shares 10-Q · filed 2025-08-07 | |||
| 2024-12-31 | 313.48K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 313.48K shares derived: sum of 2 quarters · filed 2025-02-28 | 313.48K shares derived: sum of 3 quarters · filed 2025-02-28 | 344.99K shares 10-K · filed 2025-02-28 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-07 | 31.51K shares 10-Q · filed 2024-11-07 | 232.44K shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | 31.51K shares 10-Q · filed 2024-08-01 | 232.44K shares derived: sum of 3 quarters · filed 2024-08-01 | |
| 2024-03-31 | 31.51K shares 10-Q · filed 2024-05-02 | 232.44K shares derived: sum of 2 quarters · filed 2024-05-02 | ||
| 2023-12-31 | 200.94K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | 300.77K shares 10-K · filed 2024-03-07 | ||
| 2023-09-30 | 99.83K shares 10-Q · filed 2023-11-03 | |||
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 258.39K shares derived: sum of 2 quarters · filed 2023-03-09 | 738.22K shares 10-K · filed 2023-03-09 | |
| 2022-09-30 | 258.39K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 738.22K shares 10-Q · filed 2022-11-10 | ||
| 2022-06-30 | 479.83K shares 10-Q · filed 2022-08-05 | |||
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 0.00 shares derived: sum of 2 quarters · filed 2022-03-17 | 0.00 shares derived: sum of 3 quarters · filed 2022-03-17 | 316.40K shares 10-K · filed 2022-03-17 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | 0.00 shares derived: sum of 2 quarters · filed 2021-10-28 | 316.40K shares 10-Q · filed 2021-10-28 | 673.61K shares derived: sum of 4 quarters · filed 2021-10-28 |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 316.40K shares 10-Q · filed 2021-08-05 | 673.61K shares derived: sum of 3 quarters · filed 2021-08-05 | 732.19K shares derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | 316.40K shares 10-Q · filed 2021-05-06 | 673.61K shares derived: sum of 2 quarters · filed 2021-05-06 | 732.19K shares derived: sum of 3 quarters · filed 2021-05-06 | 1.17M shares derived: sum of 4 quarters · filed 2021-05-06 |
| 2020-12-31 | 357.21K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | 415.80K shares derived: sum of 2 quarters · filed 2021-03-11 | 852.80K shares derived: sum of 3 quarters · filed 2021-03-11 | 1.04M shares 10-K · filed 2021-03-11 |
| 2020-09-30 | 58.58K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 495.58K shares derived: sum of 2 quarters · filed 2020-11-05 | 678.07K shares 10-Q · filed 2020-11-05 | 950.97K shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | 437.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 619.49K shares 10-Q · filed 2020-08-06 | 892.38K shares derived: sum of 3 quarters · filed 2020-08-06 | 1.00M shares derived: sum of 4 quarters · filed 2020-08-06 |
| 2020-03-31 | 182.49K shares 10-Q · filed 2020-05-07 | 455.38K shares derived: sum of 2 quarters · filed 2020-05-07 | 566.44K shares derived: sum of 3 quarters · filed 2020-05-07 | |
| 2019-12-31 | 272.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | 383.95K shares derived: sum of 2 quarters · filed 2020-03-12 | 404.48K shares 10-K · filed 2020-03-12 | |
| 2019-09-30 | 111.06K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 131.59K shares 10-Q · filed 2019-11-07 | ||
| 2019-06-30 | 20.53K shares 10-Q · filed 2019-08-09 | |||
| 2018-12-31 | 2.08K shares 10-K · filed 2019-03-08 | |||
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 0.00 shares 10-Q · filed 2018-08-09 | 0.00 shares derived: sum of 3 quarters · filed 2018-08-09 | 123.78K shares derived: sum of 4 quarters · filed 2018-08-09 |
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-15 | 0.00 shares derived: sum of 2 quarters · filed 2018-05-15 | 123.78K shares derived: sum of 3 quarters · filed 2018-05-15 | 151.06K shares derived: sum of 4 quarters · filed 2018-05-15 |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | 123.78K shares derived: sum of 2 quarters · filed 2018-03-29 | 151.06K shares derived: sum of 3 quarters · filed 2018-03-29 | 151.06K shares 10-K · filed 2018-03-29 |
| 2017-09-30 | 123.78K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 151.06K shares derived: sum of 2 quarters · filed 2017-11-09 | 151.06K shares 10-Q · filed 2017-11-09 | 286.07K shares derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-06-30 | 27.28K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | 27.28K shares 10-Q · filed 2017-08-07 | 162.28K shares derived: sum of 3 quarters · filed 2017-08-07 | 180.94K shares derived: sum of 4 quarters · filed 2017-08-07 |
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-05-15 | 135.00K shares derived: sum of 2 quarters · filed 2017-05-15 | 153.66K shares derived: sum of 3 quarters · filed 2017-05-15 | 162.69K shares derived: sum of 4 quarters · filed 2017-05-15 |
| 2016-12-31 | 135.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | 153.66K shares derived: sum of 2 quarters · filed 2017-03-30 | 162.69K shares derived: sum of 3 quarters · filed 2017-03-30 | 171.16K shares 10-K · filed 2017-03-30 |
| 2016-09-30 | 18.66K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | 27.69K shares derived: sum of 2 quarters · filed 2016-11-14 | 36.16K shares 10-Q · filed 2016-11-14 | |
| 2016-06-30 | 9.03K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | 17.50K shares 10-Q · filed 2016-08-10 | ||
| 2016-03-31 | 8.47K shares 10-Q · filed 2016-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |